CN109232587A - 一种具有高水溶性的瓜环及其制备方法和应用 - Google Patents
一种具有高水溶性的瓜环及其制备方法和应用 Download PDFInfo
- Publication number
- CN109232587A CN109232587A CN201810969178.5A CN201810969178A CN109232587A CN 109232587 A CN109232587 A CN 109232587A CN 201810969178 A CN201810969178 A CN 201810969178A CN 109232587 A CN109232587 A CN 109232587A
- Authority
- CN
- China
- Prior art keywords
- water
- melon
- yuan
- tetramethyl
- nitrae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/18—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, directly attached to a heterocyclic or cycloaliphatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明公开了一种具有高水溶性的瓜环及其制备方法和应用,该瓜环的名称为1,4‑四甲基八元瓜环,分子式为{[(C52H94N32O35)]•19(H2O)},分子量为1564。本发明的1,4‑四甲基八元瓜环具有良好的水溶性,并且能促进药物塞菌唑(TBZ)、多菌灵(CBZ)、吉非替尼(GEF)、拉帕替尼(LD)等在水中具有良好的溶解效果,极大地解决了药品生产过程中药物难溶的问题,提供了生产效率和药物利用率。本发明中1,4‑四甲基取代八元瓜环的制备方法过程简单,制造成本低,成品产率高。
Description
技术领域
本发明涉及超分子化学技术领域,具体说是一种具有高水溶性的瓜环及其制备方法和应用。
背景技术
瓜环(Cucurbit[n]urils,Q[n]s)因持有疏水性空腔、极性羰基修饰端口以及外壁正电性的特点,促进了瓜环的主客体化学、瓜环的配位化学等领域的发展,尤其是促进瓜环作为基本构件,构筑新颖的瓜环基超分子自组装体的发展,挖掘其潜在的特殊功能性质。在瓜环家族中,普通八元瓜环在水中的溶解性非常低,仅强酸中才能溶解。
药品生产过程中,很多药物成分的溶解性很低,比如塞菌唑、多菌灵、吉非替尼(GEF)、拉帕替尼(LD)等在水中的溶解性都很低,目前尚没有效果好的助溶剂。如杀菌剂如噻菌灵(TBZ)能防治多种作物的真菌病害和根腐病,兼有保护和治疗作用,并可作为水果的保鲜剂和防腐剂;多菌灵(CBZ)可干扰病原菌有丝分裂中纺锤体的形成,影响细胞分裂,从而起到杀菌作用。但是大多数苯并咪唑杀菌剂来说,其水溶性都相对较小甚至不溶,而是多数溶解在有机溶剂中。这就在一定程度上限制了此类杀菌剂农药的广泛、有效利用。因此,能够使其较大幅度的提高水溶性,是实现生态农业甚至可持续性农业发展的助推器。吉非替尼(GEF)和拉帕替尼(LD)是属于目前治疗恶性肿瘤的化学药物,但由于药物水溶性,无靶向性,对其他器官的毒性以及药物的耐药问题,限制了其临床应用。通过超分子自组装纳来材料的介导作用,可以大大改善药物的水溶性,提高药物的生物利用度,实现对载药量和药物释放速度的可控性。
发明内容
本发明的目的是针对上述现有技术中的不足,提供一种具有高水溶性的瓜环及其作为药物助溶剂的应用。
本发明的另一目的是提供一种具有高水溶性的瓜环的制备方法。
本发明的目的是通过以下技术方案实现的:
一种具有高水溶性的瓜环,该瓜环的名称为1,4-四甲基八元瓜环(1,4-TMeQ[8]),分子式为{[(C52H94N32O35)]·19(H2O)},分子量为1564,晶体结构为:
上述的具有高水溶性的瓜环的制备方法,具体步骤如下:
步骤1,将甲基苷脲二醚和普通苷脲二聚体按摩尔比1:1充分混合,得A品。
步骤2,将步骤1得到的A品加入12mol/L的浓盐酸中,浓盐酸按每克A 品使用2.0-4.0mL浓盐酸进行配比,在温度为70-80℃温度下加热回流6-7小时后,冷却至室温,加水稀释酸后蒸发浓缩,使用20%氢氧化铵调pH至4,减压过滤除去白色固体沉淀,将滤液蒸发浓缩至粘稠状固体,用水洗涤粘稠状固体以去除NH4Cl,得固体B品。
步骤3,向步骤2得到的B品中加入甲酸,充分溶解后得到深红色溶液,并蒸发浓缩,产生白色沉淀物,减压抽滤收集白色沉淀物,洗涤、干燥后得到1,4- 四甲基八元瓜环。
本发明进一步设计方案中,步骤2中浓盐酸的使用量为按照每克普通苷脲二聚体加11-12ml浓盐酸的比例。
上述的具有高水溶性的瓜环作为促进药物溶解的助溶剂的应用。
本发明进一步设计方案中,上述药物包括塞菌唑(TBZ)、多菌灵(CBZ)、吉非替尼(GEF)和拉帕替尼(LD)。
本发明具有以下突出的有益效果:
本发明的1,4-四甲基取代八元瓜环(1,4-TMeQ[8])在水中具有较好的溶解性,这与和大多数改性瓜环中较为少见,利用其大空腔特点,将在主客体方面的研究将得到了很大改观。本发明的1,4-四甲基取代八元瓜环能促进药物塞菌唑 (TBZ)、多菌灵(CBZ)、吉非替尼(GEF)、拉帕替尼(LD)等在水中具有良好的溶解效果,可以用作药物的助溶剂,极大地解决了药品生产过程中药物难溶的问题,提供了生产效率和药物利用率。本发明中1,4-四甲基取代八元瓜环的制备方法过程简单,制造成本低,成品产率高。
附图说明
图1是本发明的1,4-四甲基八元瓜环(1,4-TMeQ[8])晶体结构图,其中, (a)为主视图,(b)为侧视图;
图2是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])的核磁表征;
图3是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])的质谱结果;
图4是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通八元瓜环(Q[8]) 的热重分析;
图5是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通八元瓜环(Q[8]) 的红外分析;
图6是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体 TBZ的核磁滴定1H谱图;
图7是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体 CBZ的核磁滴定1H谱图;
图8是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体 GEF的核磁滴定1H谱图;
图9是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体 LD的核磁滴定1H谱图;
图10是实施例中1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通的八元瓜环 (Q[8])对药物的促溶效果对比图;
具体实施方式
下面结合附图及实施例对本发明作进一步说明。
实施例1
步骤1,将甲基苷脲二醚11.8克和普通苷脲二聚体9.8克充分混合,得A品 21.6g;
步骤2,将步骤1得到的A品加入12mol/L的浓盐酸60mL中,在温度为 70-80℃温度下加热回流6-7小时后,冷却至室温,加5L水稀释,旋转蒸发器浓缩至200mL,使用质量百分浓度为20%氢氧化铵调pH至4,减压过滤除去白色固体沉淀,将滤液用旋转蒸发仪加热蒸发浓缩至粘稠状固体后,并中加入200mL水洗涤除去NH4Cl,过滤得固体B品;
步骤3,向步骤2得到的B品中加入甲酸200mL,充分溶解后得到深红色溶液,并在旋转蒸发器浓缩至60mL左右,体系中出现白色沉淀物,减压抽滤收集出现的白色沉淀物,并用少量水洗涤、干燥,得到0.38g的1,4-四甲基八元瓜环。以甲基苷脲二醚和普通苷脲二聚体的投入的量计算,产率为4%。
对产物1,4-四甲基八元瓜环采用X-射线单晶衍射、IR、DSC-TG、1HNMR 等分析手段进行结构、性质等表征,结果如下:
附图2为1,4-四甲基八元瓜环(1,4-TMeQ[8])的核磁表征。从图2的1,4- 四甲基取代八元瓜环核磁谱图可以看出,在1.74处的甲基的氢峰H,3.88-4.33 之间为桥联亚甲基上朝外的氢峰H,5.20-5.46之间为为瓜环腰上的氢峰吃甲基H, 5.48-5.77之间为桥联亚甲基上朝内的氢峰H,四种氢峰的积分面积比为 12.00:15.96:12.15:16.10≈3:4:3:4。与1,4-四甲基取代八元瓜环三者相应氢的理论比例3:4:3:4接近,可确定为1,4-四甲基取代八元瓜环。
附图3为1,4-四甲基八元瓜环(1,4-TMeQ[8])的质谱结果。1,4-四甲基八元瓜环质谱图中峰m/z=715.2179为[1,4-TMeQ[8]-Na+]/2,可确定1,4-四甲基八元瓜环的存在。
附图4为1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通八元瓜环(Q[8])的热重分析。从TG曲线可以看出,1,4-四甲基八元瓜环粉末在220℃之前,所含有的游离水分子和结晶水分子基本挥发完,失重16.48%。从DTA曲线可以看出, 1,4-四甲基八元瓜环粉末在451.1℃时出现一个较大的吸热峰,此时1,4-四甲基八元瓜环开始分解,并产生了67.84%的失重。而普通八元瓜环在417.8℃时出现一个较大的吸热峰,八元瓜环开始分解,并产生了60.30%的失重。热重结果表明, 1,4-四甲基八元瓜环的热稳定性较普通八元瓜环有所提高。
附图5为1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通八元瓜环(Q[8])的红外谱图分析。谱图表明:1,4-四甲基八元瓜环(1,4-TMeQ[8])与八元瓜环(Q[8]) 的红外谱图类似,1,4-四甲基八元瓜环(1,4-TMeQ[8])的羰基氧在1717.74cm-1 出现特征峰。
附图6为1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体TBZ的核磁滴定1H谱图。在1,4-TMeQ[8]-TBZ的核磁滴定1H谱图中,图6.e中显示TBZ的溶解度比较差,TBZ苯环上的质子峰(Ha和Hb)和呋喃环上的质子峰 (Hc,Hd和He)峰面积很小。与游离客体TBZ比较,在1,4-TMeQ[8]-TBZ作用体系中,将客体FBZ逐渐滴加到1,4-TMeQ[8]中,随着TBZ的量由2.25×10-3 mol/L(图6.b)增加到5.64×10-3mol/L(图6.c),再增加到8.75×10-3mol/L,可见TBZ苯环上的质子峰(Ha和Hb)和呋喃环上的质子峰(Hc,Hd和He) 的峰面积逐渐增大(如图6b-d所示),即TBZ的溶解度逐渐提高,定性说明 1,4-TMeQ[8]可以提高FBZ的溶解度。
附图7为1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体CBZ的核磁滴定1H谱图。在1,4-TMeQ[8]-CBZ的核磁滴定1H谱图中,图7.d中显示 CBZ的溶解度很差,CBZ苯环上的质子峰(Ha和Hb)基本看不到,甲基峰(Hc) 也不明显。与游离客体CBZ比较,在1,4-TMeQ[8]-CBZ作用体系中,将客体CBZ 逐渐滴加到1,4-TMeQ[8]中,随着CBZ量由1.93×10-3mol/L(图7.b)增加到 4.86×10-3mol/L(图7.c),可见CBZ苯环上的质子峰(Ha和Hb)和甲基峰(Hc) 的峰面积逐渐增大(如图7b,c所示),即CBZ的溶解度逐渐提高,定性说明 1,4-TMeQ[8]可以提高CBZ的溶解度。
附图8为1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体GEF的核磁滴定1H谱图。在1,4-TMeQ[8]-GEF的核磁滴定1H谱图中,图8e中显示 GEF苯环上的质子峰基本看不到。与游离客体GEF比较,在1,4-TMeQ[8]-GEF 作用体系中,将客体GEF逐渐滴加到1,4-TMeQ[8]中,随着GEF量由0.63×10-3 mol/L(图8.b)增加到1.27×10-3mol/L(图8.c),再增加到3.99×10-3mol/L,核磁滴定上可能因1,4-TMeQ[8]与GEF作用多样,而未出现明确的化学位移,但是体系为澄清溶液,即GEF的溶解度也是逐渐提高,定性说明1,4-TMeQ[8]可以提高GEF的溶解度。
附图9为1,4-四甲基八元瓜环(1,4-TMeQ[8])在氘代水中加入客体LD的核磁滴定1H谱图。在1,4-TMeQ[8]-LD的核磁滴定1H谱图中,图9d中显示LD 苯环上的质子峰基本看不到。与游离客体LD比较,在1,4-TMeQ[8]-LD作用体系中,将客体GEF逐渐滴加到1,4-TMeQ[8]中,随着LD量由0.65×10-3mol/L (图9.b)增加到7.9×10-3mol/L(图9.c),核磁滴定上可能因1,4-TMeQ[8]与 LD作用多样,而未出现明确的化学位移,但是体系为澄清溶液,即LD的溶解度也是逐渐提高,定性说明1,4-TMeQ[8]可以提高LD的溶解度。
从上述验证结果可以得出,1,4-四甲基八元瓜环(1,4-TMeQ[8])的分子式为{[(C52H94N32O35)]·19(H2O)},分子量为1564,结构式参见附图1。
附图10为1,4-四甲基八元瓜环(1,4-TMeQ[8])与普通的八元瓜环(Q[8]) 对药物的促溶效果对比图。具体实验方法为:固定1,4-TMeQ[8](1.92×10-3 mol/L)的量,分别逐渐加入相应客体(FBZ,CBZ,GEF,LD)的浑浊液,在20℃下测定1H NMR谱,重复上述过程,直至客体过量,收集分析不同主-客体比例的1H NMR谱。
以上是本发明的较佳实施例,凡依本发明技术方案所作的改变,所产生的功能作用未超出本发明技术方案的范围时,均属于本发明的保护范围。
Claims (5)
1.一种具有高水溶性的瓜环,其特征在于,该瓜环的名称为1,4-四甲基八元瓜环,分子式为{[(C52H94N32O35)]·19(H2O)},分子量为1564,晶体结构为:
2.权利要求1所述的具有高水溶性的瓜环的制备方法,其特征在于,具体步骤如下:
步骤1,将甲基苷脲二醚和普通苷脲二聚体按摩尔比1:1充分混合,得A品;
步骤2,将步骤1得到的A品加入12mol/L的浓盐酸中,浓盐酸按每克A品使用2.0-4.0mL浓盐酸进行配比,在温度为70-80℃温度下加热回流6-7小时后,冷却至室温,加水稀释酸后蒸发浓缩,使用20%氢氧化铵调pH至4,减压过滤除去白色固体沉淀,将滤液蒸发浓缩至粘稠状固体,用水洗涤粘稠状固体以去除NH4Cl,得固体B品;
步骤3,向步骤2得到的B品中加入甲酸,充分溶解后得到深红色溶液,并蒸发浓缩,产生白色沉淀物,减压抽滤收集白色沉淀物,洗涤、干燥后得到1,4-四甲基八元瓜环。
3.根据权利要求2所述的具有高水溶性的瓜环的制备方法,其特征在于,步骤2中浓盐酸的使用量为按照每克普通苷脲二聚体加11-12ml浓盐酸的比例。
4.权利要求1所述的具有高水溶性的瓜环作为促进药物溶解的助溶剂的应用。
5.根据权利要求4所述的具有高水溶性的瓜环的应用,其特征在于,所述药物包括塞菌唑(TBZ)、多菌灵(CBZ)、吉非替尼(GEF)和拉帕替尼(LD)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810969178.5A CN109232587A (zh) | 2018-08-23 | 2018-08-23 | 一种具有高水溶性的瓜环及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810969178.5A CN109232587A (zh) | 2018-08-23 | 2018-08-23 | 一种具有高水溶性的瓜环及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109232587A true CN109232587A (zh) | 2019-01-18 |
Family
ID=65069138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810969178.5A Pending CN109232587A (zh) | 2018-08-23 | 2018-08-23 | 一种具有高水溶性的瓜环及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109232587A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115819428A (zh) * | 2022-07-14 | 2023-03-21 | 贵州大学 | 一种甲氧苄啶@八元瓜环包合物及其制备与应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007106144A1 (en) * | 2006-02-28 | 2007-09-20 | University Of Maryland | NOR-SECO-, BIS-NOR-SECO, TRIS-NOR-SECO- AND HIGHER NOR-SECO- CUCURBIT[n]URIL COMPOUNDS |
CN101307142A (zh) * | 2007-11-27 | 2008-11-19 | 南开大学 | 葫芦[7]脲苯胺纳米超分子导电聚合物及其制备方法与用途 |
CN105104374A (zh) * | 2015-09-08 | 2015-12-02 | 贵州大学 | 一种高效增加苯并咪唑类农药在水中溶解度的方法 |
CN107722025A (zh) * | 2017-11-13 | 2018-02-23 | 贵州大学 | 一种反式六甲基六元瓜环及制备方法和应用 |
-
2018
- 2018-08-23 CN CN201810969178.5A patent/CN109232587A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007106144A1 (en) * | 2006-02-28 | 2007-09-20 | University Of Maryland | NOR-SECO-, BIS-NOR-SECO, TRIS-NOR-SECO- AND HIGHER NOR-SECO- CUCURBIT[n]URIL COMPOUNDS |
CN101307142A (zh) * | 2007-11-27 | 2008-11-19 | 南开大学 | 葫芦[7]脲苯胺纳米超分子导电聚合物及其制备方法与用途 |
CN105104374A (zh) * | 2015-09-08 | 2015-12-02 | 贵州大学 | 一种高效增加苯并咪唑类农药在水中溶解度的方法 |
CN107722025A (zh) * | 2017-11-13 | 2018-02-23 | 贵州大学 | 一种反式六甲基六元瓜环及制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
BRITTANY VINCIGUERRA等,: ""Synthesis and Recognition Properties of Cucurbit[8]uril Derivatives"及其Supporting Information", 《ORG. LETT.》 * |
YING HUANG等,: ""Cucurbit[7,8]urils binding to gefitinib and the effect of complex formation on the solubility and dissolution rate of the drug"", 《RSC ADV.》 * |
席芸芸等,: ""瓜环对抗癌药物二甲苯磺酸拉帕替尼溶解度及溶出度的影响研究"", 《贵州大学学报( 自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115819428A (zh) * | 2022-07-14 | 2023-03-21 | 贵州大学 | 一种甲氧苄啶@八元瓜环包合物及其制备与应用 |
CN115819428B (zh) * | 2022-07-14 | 2024-04-26 | 贵州大学 | 一种甲氧苄啶@八元瓜环包合物及其制备与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105131152B (zh) | 一种海洋生物多糖铜复合物及制备和作为农用杀菌剂的应用 | |
CN101157734B (zh) | 壳聚糖α-氨基烷基膦酸酯类衍生物及其制备方法 | |
CN109232587A (zh) | 一种具有高水溶性的瓜环及其制备方法和应用 | |
RU2374254C1 (ru) | Стимулятор для предпосевной и внекорневой обработки семян | |
CN105061636A (zh) | 一种壳聚糖-柠檬酸-稀土配合物的制备方法 | |
CN106633093B (zh) | N-(2-异丙酸)对羟基苯甲酰腙铅配合物及其制备方法和应用 | |
CN105884833A (zh) | 一种含4,4’-二溴-2,2’-联吡啶的新型钌配合物的制备方法及其抗肿瘤活性 | |
CN109776623B (zh) | 一种含氟草酰胺同/异核化合物的制备方法与应用 | |
CN102718888A (zh) | 一种壳聚糖二硫代氨基甲酸盐衍生物及其制备方法 | |
CN102229600B (zh) | 含1,4-二氢吡啶环的顺式新烟碱类化合物及其制备方法和应用 | |
CN100443505C (zh) | 2-壳聚糖·水杨酸接枝化合物及其制备方法 | |
CN101423440B (zh) | 一种海藻酸碘水剂药肥及其制备方法 | |
CN102718886A (zh) | 一种壳聚糖1,2,4-三唑类衍生物及其制备方法 | |
CN104231006A (zh) | 一种含二茂铁基查尔酮氨基(硫)脲Schiff碱、制备方法及其应用 | |
CN102180992B (zh) | 一种壳聚糖缩取代苯氨基硫脲衍生物及其制备方法 | |
CN103524418A (zh) | 一组3-甲基吡唑化合物 | |
CN101343277A (zh) | 氨基甲酸鱼藤酮肟酯及其制备方法与应用 | |
Johari et al. | Zinc Layered Hydroxide 2-methyl-4-chlorophenoxyacetate: Synthesis via ZnO, Characterization and Effect on Seed Germination | |
CN102718722B (zh) | 一种水油兼溶的新型芳氧苯氧羧酸酯类衍生物制备及应用研究 | |
Hassan et al. | Synthesis and characterization of benzohydroxamic acid metal complexes and their cytotoxicity study | |
FI59997C (fi) | Nya 2-bensimidazol-karbaminsyraesterderivat med icke-terapeutisk fungicid och ovicid verkan | |
CN110183389A (zh) | 一种三唑硫酮类衍生化合物及制备方法 | |
RU2327686C1 (ru) | 4-метил-2-хлор-6-{[1-алкил-2-(нитробензилиден)]гидразино}-никотинонитрилы в качестве регулятора роста сахарной свеклы | |
CN110621158A (zh) | 作为降低荚果落粒性的密封剂的葫芦脲 | |
Yan et al. | Development of fully water-soluble ammonium polyphosphate-rare earth slow-release fertilizer and its application effect to vegetables. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190118 |